Cancer and thrombosis: an increasingly important association

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Wolfgang Korte

Abstract

The association of cancer and venous thromboembolism (VTE) becomes increasingly important. VTE has been recognised as an increasingly frequent complication in cancer care. Furthermore, recent clinical trials have shown that therapy and prophylaxis of VTEs with low-molecular weight heparin (LMWH) is, in general, superior to oral anticoagulation with warfarin. Also, prolonged therapy of or prophylaxis for VTE in cancer patients seems to be associated with an improved outcome. Research on patient preferences for therapy and prophylaxis of VTE is still rare; but it seems clear that, as in other areas, cancer patients wish to be involved in the decision-making process. Patients seem to accept LMWH over oral anticoagulation despite the need for subcutaneous injections. Cancer and thrombosis/hypercoagulability is an increasingly important association. The use of antithrombotics in cancer patients warrants increased attention since it's importance seems underrecognized.

References

Feb 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T SaphnerR Gray
Mar 1, 1986·The Journal of Experimental Medicine·P P Nawroth, D M Stern
Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
May 1, 1997·The British Journal of Surgery·D Bergqvist, M Björck
Mar 31, 1998·Palliative Medicine·M J Johnson, K Sherry
Apr 29, 1998·The New England Journal of Medicine·H T SørensenG L Nielsen
Jul 11, 1998·Lancet·J A BaronM Linet
Apr 10, 1999·Clinical and Laboratory Haematology·M J JohnsonJ Conkie
Jun 5, 1999·Seminars in Thrombosis and Hemostasis·A Falanga, F R Rickles
Jan 15, 2000·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·A GirolamiB Girolami
Dec 16, 2000·The New England Journal of Medicine·H T SørensenJ A Baron
Aug 23, 2001·Thrombosis Research·F R Rickles, A Falanga
Mar 29, 2002·The New England Journal of Medicine·David BergqvistUNKNOWN ENOXACAN II Investigators
May 21, 2003·Journal of Vascular Surgery·Jules LinPeter K Henke
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·M N LevineA K Kakkar
Sep 13, 2003·BMJ : British Medical Journal·C C KirwanC N McCollum
Sep 27, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine DugganJack Cuzick
May 14, 2004·Journal of Thrombosis and Haemostasis : JTH·A PiccioliUNKNOWN SOMIT Investigators Group
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K KakkarRobin C N Williamson
Oct 13, 2004·The Oncologist·Jose Pereira, Tien Phan
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sabah SallahNam P Nguyen
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clara P W KlerkHarry R Büller
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Agnes Y Y LeeMark N Levine
Feb 12, 2005·Seminars in Thrombosis and Hemostasis·Anna Falanga
Jun 1, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SiragusaN Gebbia
Nov 9, 2005·Seminars in Thrombosis and Hemostasis·Christopher O Nessel

❮ Previous
Next ❯

Citations

Nov 29, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Verena GartnerUNKNOWN AUPACS group
Mar 25, 2014·Journal of the American College of Surgeons·Robert M Van HarenKenneth G Proctor
Apr 12, 2011·Journal of Surgical Oncology·Peter J DipascoFrederick L Moffat
Oct 5, 2019·Journal of Clinical Medicine·Valli De ReMaurizio Mascarin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.